Takeda Pharmaceutical Company Limited
Heterocyclic compound

Abstract:

Provided is a heterocyclic compound that may have a GCN2 inhibitory action, and is expected to be useful for the prophylaxis or treatment of GCN2 associated diseases including cancer and the like. A compound represented by the formula (I): ##STR00001## wherein each symbol is as described in the DESCRIPTION, or a salt thereof.